Novartis AG EBIT 2012-2026 | NVS

Novartis AG EBIT for the quarter ending March 31, 2026 was $4.235B, a 9.18% decline year-over-year.

  • Novartis AG 2025 EBIT was 17.644B, a 21.31% increase from 2024.
  • Novartis AG 2024 EBIT was 14.544B, a 48.88% increase from 2023.
  • Novartis AG 2023 EBIT was 9.769B, a 22.94% increase from 2022.

EBIT can be defined as earnings before interest and taxes.

Novartis AG EBIT 2012-2026 | NVS

  • Novartis AG 2025 EBIT was 17.644B, a 21.31% increase from 2024.
  • Novartis AG 2024 EBIT was 14.544B, a 48.88% increase from 2023.
  • Novartis AG 2023 EBIT was 9.769B, a 22.94% increase from 2022.

EBIT can be defined as earnings before interest and taxes.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$887.6B
Johnson & Johnson (JNJ)$574.4B
AbbVie (ABBV)$367.7B
Roche Holding AG (RHHBY)$318.8B
Merck (MRK)$299.9B
Novo Nordisk (NVO)$167.5B
Pfizer (PFE)$153.1B
Sanofi (SNY)$114B
Bayer (BAYRY)$46.2B
Innoviva (INVA)$1.8B